RU2008148542A - Усилитель выработки тестостерона - Google Patents

Усилитель выработки тестостерона Download PDF

Info

Publication number
RU2008148542A
RU2008148542A RU2008148542/15A RU2008148542A RU2008148542A RU 2008148542 A RU2008148542 A RU 2008148542A RU 2008148542/15 A RU2008148542/15 A RU 2008148542/15A RU 2008148542 A RU2008148542 A RU 2008148542A RU 2008148542 A RU2008148542 A RU 2008148542A
Authority
RU
Russia
Prior art keywords
vitamin
testosterone
enhancer
testosterone production
menaquinone
Prior art date
Application number
RU2008148542/15A
Other languages
English (en)
Other versions
RU2431475C2 (ru
Inventor
Мичио КОМАИ (JP)
Мичио КОМАИ
Хитоши ШИРАКАВА (JP)
Хитоши ШИРАКАВА
Юсике ОХСАКИ (JP)
Юсике ОХСАКИ
Тадаши ТАКУМИ (JP)
Тадаши ТАКУМИ
Асаги ИТО (JP)
Асаги ИТО
Тоширо САТО (JP)
Тоширо САТО
Руми ОЗАКИ (JP)
Руми ОЗАКИ
Original Assignee
Й-Оил Миллс, Инц. (Jp)
Й-Оил Миллс, Инц.
Тохоку Университет (Jp)
Тохоку Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Й-Оил Миллс, Инц. (Jp), Й-Оил Миллс, Инц., Тохоку Университет (Jp), Тохоку Университет filed Critical Й-Оил Миллс, Инц. (Jp)
Publication of RU2008148542A publication Critical patent/RU2008148542A/ru
Application granted granted Critical
Publication of RU2431475C2 publication Critical patent/RU2431475C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1. Усилитель выработки тестостерона, включающий витамин К в качестве активного ингредиента. ! 2. Усилитель выработки тестостерона по п.1, отличающийся тем, что витамин К является витамином К2. ! 3. Усилитель выработки тестостерона по п.1, отличающийся тем, что описанный выше витамин К является менахиноном-4 и/или менахиноном-7. ! 4. Лекарство, которое предотвращает появление и/или лечит симптомы или заболевания, вызванные снижением тестостерона, созданные на основе усилителя выработки тестостерона, который включает витамин К в качестве активного компонента. ! 5. Добавка, диетическая пища, пищевые продукты, содержащие добавки, которые содержат усилитель тестостерона, включая витамин К в качестве активного компонента.

Claims (5)

1. Усилитель выработки тестостерона, включающий витамин К в качестве активного ингредиента.
2. Усилитель выработки тестостерона по п.1, отличающийся тем, что витамин К является витамином К2.
3. Усилитель выработки тестостерона по п.1, отличающийся тем, что описанный выше витамин К является менахиноном-4 и/или менахиноном-7.
4. Лекарство, которое предотвращает появление и/или лечит симптомы или заболевания, вызванные снижением тестостерона, созданные на основе усилителя выработки тестостерона, который включает витамин К в качестве активного компонента.
5. Добавка, диетическая пища, пищевые продукты, содержащие добавки, которые содержат усилитель тестостерона, включая витамин К в качестве активного компонента.
RU2008148542/15A 2006-06-23 2007-05-21 Усилитель выработки тестостерона RU2431475C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-173455 2006-06-23
JP2006173455 2006-06-23

Publications (2)

Publication Number Publication Date
RU2008148542A true RU2008148542A (ru) 2010-06-20
RU2431475C2 RU2431475C2 (ru) 2011-10-20

Family

ID=38833237

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008148542/15A RU2431475C2 (ru) 2006-06-23 2007-05-21 Усилитель выработки тестостерона

Country Status (7)

Country Link
US (2) US8686049B2 (ru)
EP (1) EP2033634A4 (ru)
JP (1) JP5110478B2 (ru)
KR (1) KR20090023562A (ru)
CN (1) CN101472574B (ru)
RU (1) RU2431475C2 (ru)
WO (1) WO2007148494A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140171918A1 (en) * 2012-12-14 2014-06-19 Bioject, Inc. Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men
WO2023170591A2 (en) * 2022-03-09 2023-09-14 Synergia Life Sciences Pvt Ltd. Novel menaquinone-n (vitamin-k2-7) supplementation for livestock and poultry

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2943031B2 (ja) 1991-11-30 1999-08-30 株式会社ホーネンコーポレーション 天然ビタミンk濃縮物の製造方法
JP2900238B2 (ja) 1994-07-07 1999-06-02 株式会社ホーネンコーポレーション 天然メナキノン−7高含量脂質
JP3845923B2 (ja) 1996-12-10 2006-11-15 熊本製粉株式会社 食品用ビタミンk補給組成物の製造方法
JPH10295393A (ja) 1997-04-30 1998-11-10 New Food Kurieeshiyon Gijutsu Kenkyu Kumiai ビタミンkの製造法
JPH1156232A (ja) 1997-08-26 1999-03-02 Snow Brand Milk Prod Co Ltd ビタミンk及びカルシウムを強化した乳及び乳製品
JP3876395B2 (ja) 1997-09-25 2007-01-31 株式会社J−オイルミルズ ビタミンk2濃縮物の製造法
JPH11127816A (ja) 1997-10-27 1999-05-18 Sanei Gen Ffi Inc ビタミンkを含有する食品
JP3836242B2 (ja) * 1998-01-16 2006-10-25 陽子 竹中 ビタミンk類及び機能性食品の製造方法並びに機能性食品
US6093421A (en) 1999-08-31 2000-07-25 Biotics Research Corporation Maca and antler for augmenting testosterone levels
JP2001136959A (ja) 1999-11-17 2001-05-22 Hiroyuki Sumi 枯草菌菌体および/またはその産生物を含む培養物、これに由来する水溶性ビタミンk誘導体、これらを含む医薬、食品および飼料ならびにこれらの製造方法
JP4131443B2 (ja) 2001-08-27 2008-08-13 株式会社J−オイルミルズ 抗骨粗鬆症組成物
CA2458661A1 (en) 2001-09-27 2003-04-03 Applied Research Systems Ars Holding N.V. Methods of increasing endogenous testosterone levels
JP2003226639A (ja) * 2002-01-31 2003-08-12 Hisamitsu Pharmaceut Co Inc 神経成長因子活性増強剤としてのビタミンk類を含む医薬組成物およびその使用
JP2005306754A (ja) 2004-04-19 2005-11-04 Towa Corporation 株式会社 テストステロン増加組成物、テストステロン増加食品、テストステロン増加皮膚外用およびテストステロン増加薬

Also Published As

Publication number Publication date
EP2033634A4 (en) 2010-12-22
US20140228447A1 (en) 2014-08-14
CN101472574A (zh) 2009-07-01
JP5110478B2 (ja) 2012-12-26
WO2007148494A1 (ja) 2007-12-27
EP2033634A1 (en) 2009-03-11
RU2431475C2 (ru) 2011-10-20
US20090209653A1 (en) 2009-08-20
JPWO2007148494A1 (ja) 2009-11-19
CN101472574B (zh) 2011-06-15
KR20090023562A (ko) 2009-03-05
US8686049B2 (en) 2014-04-01

Similar Documents

Publication Publication Date Title
DK1455603T3 (da) Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
ATE442050T1 (de) Nahrungsergänzungsmittel oder functional food enthaltend íl-kombination
NO20075009L (no) Ernaeringstilsetning for HIV-pasienter
TW200736213A (en) Dicarboxylic acid derivatives and their use
MY142017A (en) Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
WO2006112717A3 (en) Nutritional supplement for a category of hiv patients
BRPI0612848A8 (pt) manopartículas de isoflavona e usos das mesmas
EP2241196A3 (en) Nutritional supplement comprising oligosaccharides and cysteine for treating hiv
TW200612903A (en) Use of trisubstituted benzopyranones
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür
MXPA04000834A (es) Suplementos dieteticos de vinasa de vino y un proceso importante de produccion.
EP1898712A4 (en) CEREAL SOUND ENRICHED FOR THE PROMOTION OF DIGESTIVE HEALTH
RU2009134848A (ru) Транквилизатор и функциональный продукт питания
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
TW200745132A (en) Novel, acyclically substituted furopyrimidine derivatives and use thereof
WJABN et al. Anti-Inflammatory Activity of Pleurotus ostreatus, a Culinary Medicinal Mushroom, in Wistar Rats.
RU2008148542A (ru) Усилитель выработки тестостерона
WO2007031140A3 (de) Extrakte aus epimedium-arten, verfahren zu ihrer herstellung und verwendung
EA201200856A1 (ru) Биологически активная добавка к пище для профилактики заболеваний и оздоровления сердечно-сосудистой системы
ATE435595T1 (de) Tafeloliven, die probiotische mikroorganismen enthalten
CN104187690A (zh) 一种改善老年人智力的食品
WO2008108284A1 (ja) Rankl産生抑制剤
Kasonga et al. Arachidonic acid and docosahexaenoic acid inhibits osteoclastogenesis and bone resorption in human CD14+ monocytes, in vitro
TH97953B (th) สารปรับปรุงการเมทาบอลิสมไขมัน

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20160522